EASLnews (@easlnews) 's Twitter Profile
EASLnews

@easlnews

Let's unite Hepatology! Become a member today and discover your membership benefits.
____________
RT ≠ endorsement. We express no political views.

ID: 317662616

linkhttps://easl.eu calendar_today15-06-2011 08:35:34

16,16K Tweet

21,21K Followers

4,4K Following

EASLnews (@easlnews) 's Twitter Profile Photo
EASLnews
@easlnews

a year ago

After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of life and long-term prognosis have been greatly affected by this challenging disease.

After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of life and long-term prognosis have been greatly affected by this challenging disease.